More than one in ten patients seen by new cancer diagnostic services have been referred for cancer treatment, helping to speed up treatment and improve outcomes. Patients waited an average of 14 days from referral, to having cancer ruled in or out.
A novel approach to sleep ‘prehabilitation’ is to be trialled with newly-diagnosed breast cancer patients suffering from early signs of insomnia, in research by the University of Strathclyde and the NHS.
Technology designed for patients to make informed choices is “the only way” to take Scotland’s medical model into the 21st century, according to the head of an innovation centre hosted at the University of Strathclyde.
New findings from a three-year observational extension of the landmark Diabetes Remission Clinical Trial DiRECT reveal that, for those in remission from type 2 diabetes at the end of year two of the original study, 26% still remained in remission at year five. The overall remission rate was 13% of…
Founded in 2020, SOLASTA Bio has developed what’s been said to be the world’s first technology platform for creating neuropeptide-based insect control agents (ICAs)—bioinsecticides that aren’t based on synthetic chemicals, are environmentally-friendly, and can help preserve the ecosystem by protecting beneficial pollinators.
We like to share what’s happening in our sectors across Glasgow and the West of Scotland. If you have a news story that you think would be of interest to our partners and community, please get in touch at info@glasgowcityof